These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 26604924)
1. Galectin-3 and Cyclin D3 Immunohistochemistry and Tumor Dimensions Are Useful in Distinguishing Follicular Oncocytic Carcinomas from Oncocytic Adenomas of the Thyroid. Cacchi C; Arnholdt HM; Haas CJ; Kretsinger H; Axt L; Märkl B Int J Endocrinol; 2015; 2015():276854. PubMed ID: 26604924 [TBL] [Abstract][Full Text] [Related]
2. Combined use of galectin-3 and thyroid peroxidase improves the differential diagnosis of thyroid tumors. Kalfert D; Ludvikova M; Kholova I; Ludvik J; Topolocan O; Plzak J Neoplasma; 2020 Jan; 67(1):164-170. PubMed ID: 31777257 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of CD15, galectin-3 and HBME-1 expression in follicular thyroid neoplasms]. Bogdańska M; Górnicka B; Ziarkiewicz-Wróblewska B; Koperski L; Morton M; Wasiutyński A Endokrynol Pol; 2006; 57(4):314-9. PubMed ID: 17006830 [TBL] [Abstract][Full Text] [Related]
4. Galectin-3 and HBME-1 expression in oncocytic cell tumors of the thyroid. Volante M; Bozzalla-Cassione F; DePompa R; Saggiorato E; Bartolazzi A; Orlandi F; Papotti M Virchows Arch; 2004 Aug; 445(2):183-8. PubMed ID: 15252732 [TBL] [Abstract][Full Text] [Related]
5. Hexokinase III, cyclin A and galectin-3 are overexpressed in malignant follicular thyroid nodules. Hooft L; van der Veldt AA; Hoekstra OS; Boers M; Molthoff CF; van Diest PJ Clin Endocrinol (Oxf); 2008 Feb; 68(2):252-7. PubMed ID: 17868400 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical expression of HBME-1 and galectin-3 in the differential diagnosis of follicular-derived thyroid nodules. Abd-El Raouf SM; Ibrahim TR Pathol Res Pract; 2014 Dec; 210(12):971-8. PubMed ID: 25041837 [TBL] [Abstract][Full Text] [Related]
7. Galectin-3 does not reliably distinguish benign from malignant thyroid neoplasms. Mehrotra P; Okpokam A; Bouhaidar R; Johnson SJ; Wilson JA; Davies BR; Lennard TW Histopathology; 2004 Nov; 45(5):493-500. PubMed ID: 15500653 [TBL] [Abstract][Full Text] [Related]
8. Characterization of thyroid 'follicular neoplasms' in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Saggiorato E; De Pompa R; Volante M; Cappia S; Arecco F; Dei Tos AP; Orlandi F; Papotti M Endocr Relat Cancer; 2005 Jun; 12(2):305-17. PubMed ID: 15947105 [TBL] [Abstract][Full Text] [Related]
11. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas. Nascimento MC; Bisi H; Alves VA; Longatto-Filho A; Kanamura CT; Medeiros-Neto G Endocr Pathol; 2001; 12(3):275-9. PubMed ID: 11740048 [TBL] [Abstract][Full Text] [Related]
12. Value of immunohistochemical expression of p27 and galectin-3 in differentiation between follicular adenoma and follicular carcinoma. Abulkheir IL; Mohammad DB Appl Immunohistochem Mol Morphol; 2012 Mar; 20(2):131-40. PubMed ID: 22553813 [TBL] [Abstract][Full Text] [Related]
14. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules. Beesley MF; McLaren KM Histopathology; 2002 Sep; 41(3):236-43. PubMed ID: 12207785 [TBL] [Abstract][Full Text] [Related]
15. The use of a combination of Ki-67, Galectin-3, and PTTG can distinguish the benign and malignant thyroid tumor. Cui W; Lu X; Zheng S; Ma Y; Liu X; Zhang W Clin Lab; 2012; 58(5-6):419-26. PubMed ID: 22783570 [TBL] [Abstract][Full Text] [Related]
16. Diagnostic value of TROP-2 expression in papillary thyroid carcinoma and comparison with HBME-1, galectin-3 and cytokeratin 19. Murtezaoglu AR; Gucer H Pol J Pathol; 2017; 68(1):1-10. PubMed ID: 28547974 [TBL] [Abstract][Full Text] [Related]
17. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Inohara H; Honjo Y; Yoshii T; Akahani S; Yoshida J; Hattori K; Okamoto S; Sawada T; Raz A; Kubo T Cancer; 1999 Jun; 85(11):2475-84. PubMed ID: 10357421 [TBL] [Abstract][Full Text] [Related]
18. Proliferative markers in diagnosis of thyroid tumors: a comparative study of MIB-1 and topoisomerase II-a immunostaining. Ludvíková M; Holubec L; Ryska A; Topolcan O Anticancer Res; 2005; 25(3A):1835-40. PubMed ID: 16033110 [TBL] [Abstract][Full Text] [Related]